Latest News Archive
Please select Category, Year, and then Month to display items
31 January 2018
Photo FNB Varsity Cup
Lubabalo Dobela, Shimlas flyhalf (with the ball), played a key role in the Shimlas’ win over Tuks in the first round of the 2018 Varsity Cup.
The Shimlas made a huge statement in their opening match of the 2018 Varsity Cup when they defeated last year’s champions at the Tuks Rugby Stadium in Pretoria.
The Free State students won the encounter against Tuks by 19-17 on Monday.
Tuks, who beat Shimlas twice last year, first in the group stage by 65-19, and then by 28-21 in the semifinals, were regarded as the hot favourites. The match was played in wet conditions which many thought would suit the home team better.
Determination carries team to win
But a young and inexperienced Shimlas team with 11 players making their debut in the competition proved that big hearts and guts count for just as much. It was only their third win in Pretoria in the 11th year of the competition and their second victory over Tuks since 2012.
As expected, both teams tightened up their approach. Shimlas struck back from a 0-5 deficit soon after the first strategy break as big and speedy wing Francois Agenbag stormed down the touchline to score a seven-point try. Flyhalf Lubabalo Dobela was on hand to convert and hand his team a 9-5 lead at the break.
Flyhalf stars in debut
The Shimlas extended their lead within five minutes of the restart as flank Benji Janse van Vuuren crashed over in the corner for a converted try. Dobela, one of the debutants who was named Player that Rocks (Player of the Match), controlled the match like a seasoned veteran. Apart from two difficult conversions from the touchline, he also slotted a penalty goal.
HIV Cure – Just another fantasy?
2016-07-27
Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at Oxford University.
Antiretroviral medicine therapeutic
The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.
“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.
Healthy lifestyles encouraged
The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.
Search for a cure continues
More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.